Medicare AdvantageCoverageMedium impact
MA11.105k, Aqueous Shunts, Microstents, Viscocanalostomy, and Canaloplasty for the Treatment of Glaucoma
Independence Blue Cross·Ophthalmology·Medical Policy
Effective date
Oct 1, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage updated their policy MA11.105k covering aqueous shunts, microstents, viscocanalostomy, and canaloplasty procedures for glaucoma treatment. This policy became effective October 1, 2025 and may impact coverage criteria or billing requirements for these specialized glaucoma procedures.
Action Required
By October 1, 2025: Billing team should review the complete MA11.105k policy document at the provided URL to identify any changes to coverage criteria, prior authorization requirements, or documentation needs for glaucoma procedures including aqueous shunts, microstents, viscocanalostomy, and canaloplasty. Update billing workflows accordingly for Medicare Advantage patients.